Literature DB >> 30709441

SWI/SNF Complex-Deficient Soft Tissue Neoplasms: A Pattern-Based Approach to Diagnosis and Differential Diagnosis.

Abbas Agaimy1.   

Abstract

Loss of different components of the Switch/sucrose nonfermentable (SWI/SNF) chromatin remodeling complex has been increasingly recognized as a central molecular event driving the initiation and/or dedifferentiation of mostly lethal but histogenetically diverse neoplasms in different body organs. This review summarizes and discusses the morphologic and phenotypic diversity of primary soft tissue neoplasms characterized by SWI/SNF complex deficiency with an emphasis on convergent and divergent cytoarchitectural patterns.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelioid sarcoma; Extraskeletal myxoid chondrosarcoma; INI1; Myoepithelial carcinoma; Rhabdoid tumor; SMARCA4; SMARCB1; SWI/SNF complex; Undifferentiated pediatric sarcoma

Mesh：

Substances：

Year:  2019        PMID： 30709441     DOI： 10.1016/j.path.2018.10.006

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN： 1875-9157


  11 in total

1.  SWI/SNF complex-deficient soft tissue neoplasms: An update.

Authors:  Inga-Marie Schaefer; Jason L Hornick
Journal:  Semin Diagn Pathol       Date:  2020-06-05       Impact factor: 3.464

Review 2.  What is new in epithelioid soft tissue tumors?

Authors:  Abbas Agaimy
Journal:  Virchows Arch       Date:  2019-11-04       Impact factor: 4.064

3.  The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma.

Authors:  Hayley J Zullow; Akshay Sankar; Davis R Ingram; Daniel D Samé Guerra; Andrew R D'Avino; Clayton K Collings; Rossana Lazcano; Wei-Lien Wang; Yu Liang; Jun Qi; Alexander J Lazar; Cigall Kadoch
Journal:  Mol Cell       Date:  2022-04-06       Impact factor: 19.328

4.  Cytomorphologic Spectrum of SMARCB1-Deficient Soft Tissue Neoplasms.

Authors:  Inga-Marie Schaefer; Alyaa Al-Ibraheemi; Xiaohua Qian
Journal:  Am J Clin Pathol       Date:  2021-07-06       Impact factor: 2.493

Review 5.  Primary cutaneous SMARCB1-deficient carcinoma.

Authors:  Yiang Hui; Paolo Cotzia; Satshil Rana; Brie E Kezlarian; Oscar Lin; Travis J Hollmann; Snjezana Dogan
Journal:  J Cutan Pathol       Date:  2021-03-14       Impact factor: 1.458

Review 6.  Epithelioid Cutaneous Mesenchymal Neoplasms: A Practical Diagnostic Approach.

Authors:  Joon Hyuk Choi; Jae Y Ro
Journal:  Diagnostics (Basel)       Date:  2020-04-17

7.  ARID1A deficient undifferentiated spindle cell and rhabdoid sarcoma of the prostate: report of a unique case with emphasis on diagnostic implications.

Authors:  Wenjuan Xu; Haiying Dong; Guoqing Ru; Ming Zhao
Journal:  Diagn Pathol       Date:  2022-02-06       Impact factor: 2.644

Review 8.  The SWI/SNF complex in cancer - biology, biomarkers and therapy.

Authors:  Priya Mittal; Charles W M Roberts
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

9.  Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes.

Authors:  Christopher J Schwartz; Fresia Pareja; Edaise M da Silva; Pier Selenica; Dara S Ross; Britta Weigelt; Edi Brogi; Jorge S Reis-Filho; Hannah Y Wen
Journal:  Mod Pathol       Date:  2021-06-02       Impact factor: 7.842

10.  Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group.

Authors:  M C Frühwald; K Nemes; H Boztug; M C A Cornips; D G Evans; R Farah; S Glentis; M Jorgensen; K Katsibardi; S Hirsch; K Jahnukainen; I Kventsel; K Kerl; C P Kratz; K W Pajtler; U Kordes; V Ridola; E Stutz; F Bourdeaut
Journal:  Fam Cancer       Date:  2021-02-03       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.